Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
Distributions to Estimate Population Parameter01:26

Distributions to Estimate Population Parameter

The accurate values of population parameters such as population proportion, population mean, and population standard deviation (or variance) are usually unknown. These are fixed values that can only be estimated from the data collected from the samples. The estimates of each of these parameters are sample proportion, the sample mean, and sample standard deviation (or variance). To obtain the values of these sample statistics, data are required that have particular distribution and central...
Test for Homogeneity01:23

Test for Homogeneity

The goodness–of–fit test can be used to decide whether a population fits a given distribution, but it will not suffice to decide whether two populations follow the same unknown distribution. A different test, called the test for homogeneity, can be used to conclude whether two populations have the same distribution. To calculate the test statistic for a test for homogeneity, follow the same procedure as with the test of independence. The hypotheses for the test for homogeneity can be stated as...
Binomial Probability Distribution01:15

Binomial Probability Distribution

A binomial distribution is a probability distribution for a procedure with a fixed number of trials, where each trial can have only two outcomes.
The outcomes of a binomial experiment fit a binomial probability distribution. A statistical experiment can be classified as a binomial experiment if the following conditions are met:
There are a fixed number of trials. Think of trials as repetitions of an experiment. The letter n denotes the number of trials.
There are only two possible outcomes,...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Developmental Disorders in Children Recently Diagnosed With Cancer.

Pediatric blood & cancer·2026
Same author

Association of Medicaid expansion with colon cancer care: treatment patterns and survival in non-metastatic cases from state registry-claims data.

Cancer causes & control : CCC·2025
Same author

Maternal Childhood Trauma and Children's Developmental Course of Aggressive Behavior from Ages 4 to 12.

Psychology of violence·2025
Same author

A Rising Tide Raises All Ships: Was the Effect of Medicaid Expansion on Cancer Outcomes Similar Across Subgroups of Patients With Cancer on Medicaid?

AJPM focus·2025
Same author

Validity and reliability of Brier scoring for assessment of probabilistic diagnostic reasoning.

Diagnosis (Berlin, Germany)·2024
Same author

Multilevel Interventions and Dental Attendance in Pediatric Primary Care: A Cluster Randomized Clinical Trial.

JAMA network open·2024

Related Experiment Videos

Estimating treatment effect heterogeneity for binary outcomes via Dirichlet multinomial constraints.

Edward J Masch1, Jeffrey M Albert

  • 1Department of Quantitative Health Sciences, Cleveland Clinic, 9500 Euclid Ave., Cleveland, OH 44195, USA. maschae@ccf.org

Biometrical Journal. Biometrische Zeitschrift
|July 12, 2007
PubMed
Summary

This study introduces a method to estimate

Related Experiment Videos

Area of Science:

  • Biostatistics
  • Clinical Trials
  • Epidemiology

Background:

  • Treatment effect heterogeneity (TEH) is often ignored in clinical trials.
  • The variability of causal effects across individuals is not directly estimable from observed outcomes.
  • Treatment risk, the proportion of individuals failing treatment but succeeding control, is of particular interest.

Purpose of the Study:

  • To develop a method for directly estimating treatment risk.
  • To propose a statistical test for zero treatment risk.
  • To explore implications for medical decision-making.

Main Methods:

  • Utilizing potential outcomes framework for causal inference.
  • Estimating treatment risk under Dirichlet multinomial constraints for population counts.
  • Applying methods to both randomized and non-randomized study designs.

Main Results:

  • Demonstrated direct estimation of treatment risk under specific constraints.
  • Developed a test for zero treatment risk with good size and power.
  • Showcased applicability to diverse study types.

Conclusions:

  • Direct estimation of treatment risk is feasible with specific population count constraints.
  • The proposed test effectively identifies zero treatment risk.
  • Findings have implications for personalized and policy-level medical decisions.